the contribution from radioactivity in bladder contents to dose commitments to the embryo , ovaries , red marrow , kidney , bladder wall and total body has been estimated for various renal radiopharmaceuticals , assuming a bladdervoiding period of 3.5 h .
C0005682
bladder
C0458421
bladder wall